SBIR Phase I- Topic 410 - Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement.

NIH RePORTER · NIH · N43 · $400,000 · view on reporter.nih.gov ↗

Abstract

Many clinical trials fail to meet their accrual and retention goals, which leads to delays, early termination, or inability to draw conclusions at trial completion due to loss of statistical power. NCI wants to enhance clinical trials recruitment and retention by developing tools that could enhance communication between participants and study staff. In this Phase 1 tool development application we address the NCI interest in simplified informed consent documents that enhance personal communication during the informed consent process. In this Phase I proposal we leverage natural language processing technology and our teams prior work on the Informed Consent Ontology (ICO) to improve the language in consent documents related specifically to permissions granted by a research participant.

Key facts

NIH application ID
10265762
Project number
75N91020C00017-0-9999-1
Recipient
MELAX TECHNOLOGIES, INC.
Principal Investigator
Frank Manion
Activity code
N43
Funding institute
NIH
Fiscal year
2020
Award amount
$400,000
Award type
Project period
2020-09-16 → 2021-06-15